Clinical Trial Update: Effects of the Contraceptive Implant in Women With Sickle Cell Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial to assess the effects of the etonogestrel contraceptive implant in women with sickle cell disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Nexplanon (etonogestrel implant)

Snippet

Sponsor: University of Pennsylvania | Conditions: Sickle Cell Disease | Phase 4 | Status: RECRUITING